investordatabase.org

Bain Capital Life Sciences

baincapitallifesciences.com Direct investor

Bain Capital Life Sciences is a private equity firm that invests in life science companies globally, focusing on biopharmaceutical, medical device, diagnostic, and life science tool companies. It targets opportunities such as inflection capital, growth capital, fallen angels, and transformation at scale.

Bain Capital Life Sciences is a private equity firm headquartered in Boston, United States, founded in 2016. It invests directly in companies, from growth to buyout, in pharmaceuticals, biotechnology, medical devices and diagnostics. $6.3B+ under management and 70 portfolio companies, as it reports.

“We partner with life science companies across the globe, with a focus on driving medical innovation throughout the value chain, to improve the lives of patients with unmet medical needs.”

— Bain Capital Life Sciences, own website
Layer
Direct investor
Type
Private equity
Stage
Growth – Buyout
Headquarters
Boston, United States
Invests in
global
Sectors
pharmaceuticals, biotechnology, medical devices, diagnostics, life science tools
Founded
2016
Assets under management
$6.3B+
Portfolio
70 companies

Team, as Bain Capital Life Sciences publishes it

  • Melaku Arega, MD Vice President
  • Matthew Calistri Managing Director
  • Jonah Cashdan Principal
  • Shuvam Chaudhuri, PhD Vice President
  • Isaac Cheng Vice President
  • Michael Cooney, PhD Vice President
  • Jay Corrigan Group Chief Financial Officer, Private Markets
  • Will Cozean Managing Director
  • Jennie Daisak Vice President
  • Melissa Danforth General Counsel, Life Sciences
  • Kristen Deftos Head of Human Resources, Double Impact, Life Sciences, Real Estate & Tech Opportunities
  • Nicholas Downing Partner

Names and roles exactly as listed on baincapitallifesciences.com. Nothing else about these people is recorded.

Co-invests most often with

Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 63 co-investors found.

  • RA Capital Management 12 shared companies: freenome.com, abcuro.com, invivyd.com, gsk.com…
  • Bain Capital Credit 8 shared companies: baincapital.com, baincapitalprivateequity.com, baincapitaldoubleimpact.com, baincapitalinsurance.com…
  • Bain Capital Special Situations 8 shared companies: baincapital.com, baincapitalprivateequity.com, baincapitaldoubleimpact.com, baincapitalinsurance.com…
  • Bain Capital 8 shared companies: baincapitalprivateequity.com, baincapitaldoubleimpact.com, baincapitalinsurance.com, baincapitaltechopportunities.com…
  • Atlas Venture 7 shared companies: discmedicine.com, kailera.com, kymeratx.com, nimbustx.com…
  • Frazier Life Sciences Management, LP 6 shared companies: newamsterdampharma.com, discmedicine.com, angitiabio.com, arcutis.com…
  • Avoro Capital Advisors LLC 5 shared companies: kymeratx.com, olema.com, amylyx.com, nuvalent.com…
  • OrbiMed 4 shared companies: discmedicine.com, angitiabio.com, adarx.com, upstreambio.com
  • Lightstone Ventures 4 shared companies: nimbustx.com, atsenatx.com, gynesonics.com, mersana.com
  • The Column Group 4 shared companies: vrtx.com, synthekine.com, revmed.com, nurixtx.com

and 53 more — the graph.

Where this comes from

Every fact above was read from a page Bain Capital Life Sciences publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 4275 · added 2026-09-03 · link last verified 2026-09-06 · confidence high

Similar investors

Listed under